Literature DB >> 34160782

Prolonged exposure to continuous renal replacement therapy in patients with acute kidney injury.

Khaled Shawwa1,2, Panagiotis Kompotiatis1, Ankit Sakhuja3, Paul McCarthy3, Kianoush B Kashani4,5,6.   

Abstract

BACKGROUND: Little is known about the process of deciding to discontinue continuous renal replacement therapy (CRRT) in patients with acute kidney injury (AKI) and the impact of CRRT duration on outcomes.
METHODS: We report the clinical parameters of prolonged CRRT exposure and predictors of doubling of serum creatinine or need for dialysis at 90 days after CRRT with propensity score matching, including covariates that were likely to influence patients in the prolonged CRRT group.
RESULTS: Among 104 survey responders, most use urine output (87%) to guide CRRT discontinuation, 24% use improvement in clinical or hemodynamic status. In the cohort study, of 854 included patients, 465 participated in the assessment of kidney recovery. Patients with prolonged CRRT had higher SOFA scores (11.9 vs. 11.2) and were more likely to be mechanically ventilated (99% vs. 84%) at CRRT initiation compared to patients without prolonged CRRT, p-value < 0.05. In multivariable logistic regression, daily urine output and cumulative fluid balance leading to CRRT discontinuation or day seven were independently associated with lower [OR 0.87 per 200 ml/day increase] and higher odds [OR 1.03 per 1-L increase] of requiring prolonged CRRT, respectively. After propensity score matching, prolonged exposure to CRRT was independently associated with increased risk of doubling serum creatinine or dialysis at 90 days, OR 3.1 (95% CI 1.23-8.3 p = 0.017).
CONCLUSIONS: Resolution of critical illness and signs of kidney recovery are important factors when considering CRRT discontinuation. Prolonged CRRT exposure may be associated with less chance of kidney recovery among survivors.
© 2021. Italian Society of Nephrology.

Entities:  

Keywords:  AKI; CRRT; Critical care; De-escalation; Survey

Mesh:

Substances:

Year:  2021        PMID: 34160782      PMCID: PMC8695624          DOI: 10.1007/s40620-021-01097-9

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  31 in total

Review 1.  A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.

Authors:  Valentina Pistolesi; Santo Morabito; Francesca Di Mario; Giuseppe Regolisti; Chiara Cantarelli; Enrico Fiaccadori
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  A Prospective Observational Study on the Predictive Value of Serum Cystatin C for Successful Weaning from Continuous Renal Replacement Therapy.

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Kidney Blood Press Res       Date:  2018-05-30       Impact factor: 2.687

Review 3.  Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies.

Authors:  Valentina Pistolesi; Laura Zeppilli; Enrico Fiaccadori; Giuseppe Regolisti; Luigi Tritapepe; Santo Morabito
Journal:  J Nephrol       Date:  2019-09-12       Impact factor: 3.902

4.  Survival to discharge among patients treated with continuous renal replacement therapy.

Authors:  Ron Wald; Rushi Deshpande; Chaim M Bell; Joanne M Bargman
Journal:  Hemodial Int       Date:  2006-01       Impact factor: 1.812

5.  Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies.

Authors:  Stanislao Morgera; Anne K Kraft; Gerda Siebert; Friedrich C Luft; Hans-H Neumayer
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

6.  Factors predicting successful discontinuation of continuous renal replacement therapy.

Authors:  S Katayama; S Uchino; M Uji; T Ohnuma; Y Namba; H Kawarazaki; N Toki; K Takeda; H Yasuda; J Izawa; N Tokuhira; I Nagata
Journal:  Anaesth Intensive Care       Date:  2016-07       Impact factor: 1.669

7.  Long-term prognosis after acute kidney injury requiring renal replacement therapy.

Authors:  Pierre-Alain Triverio; Pierre-Yves Martin; Jacques Romand; Jerome Pugin; Thomas Perneger; Patrick Saudan
Journal:  Nephrol Dial Transplant       Date:  2009-02-19       Impact factor: 5.992

8.  Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy.

Authors:  Stephen Fröhlich; Amy Donnelly; Orsolya Solymos; Niamh Conlon
Journal:  J Crit Care       Date:  2012-10-24       Impact factor: 3.425

9.  How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients.

Authors:  Benjamin D Bray; Jennifer Boyd; Conal Daly; Arthur Doyle; Ken Donaldson; Jonathan G Fox; Andrew Innes; Izhar Khan; Bruce Mackinnon; Robert K Peel; Ilona Shilliday; Keith Simpson; Graham A Stewart; Jamie P Traynor; Wendy Metcalfe
Journal:  Nephrol Dial Transplant       Date:  2013-09-24       Impact factor: 5.992

Review 10.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.